Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

ScinoPharm Taiwan Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SCINOPHARM TAIWAN LIMITED (1789-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Scinopharm Taiwan Limited (1789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Scinopharm Taiwan Limited (1789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ScinoPharm Taiwan, Ltd....

21 Apr 2014 GlobalData 21 $250.00

Wright Investors Service Comprehensive Report for Scinopharm Taiwan Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Apr 2014 Wright Reports 41 $75.00

Scinopharm Taiwan Limited (1789) - Financial Analysis Review

Scinopharm Taiwan Limited (1789) - Financial Analysis Review Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmace...

19 Mar 2014 GlobalData 24 $125.00

ScinoPharm Taiwan (1789 TT):Tepid Short-Term Business Outlook

Both ScinoPharm’s Changshu phase 1 and 2 plants had been completed and commenced pilot production. But, we estimate that its ...

04 Mar 2014 MasterLink Securities Corporation 5 $46.00

神隆(1789):短期營運進入沉潛期

 受折舊費用及產能利用率偏低影響,短期營運將進入沈潛期:神隆常熟一二期工程皆已順利完工,並進入產品開發試產階段,然預期2016-2017年完成法規單位查廠,屆時新產能方可正式生產銷售,短期因產能完工必須提列相關折舊費用,神隆2013年折舊費用約4....

18 Feb 2014 MasterLink Securities Corporation 4 $23.00

神隆(1789.TT)獲利下調且評價合理,維持中立

獲利下調且評價合理,維持中立建議:投資建議部分,以2013、2014年稅後EPS為設算基準,目前本益比逾40倍,評價仍不低,加以常熟廠可正式對外銷售及針劑廠營收開始貢獻預計皆須到2016年以後,故維持中立建議。 營運現況與分析:

17 Feb 2014 SinoPac Sec Investment Service Traditional Chinese 5 $35.00

Scinopharm Taiwan Limited (1789) - Financial Analysis Review

Scinopharm Taiwan Limited (1789) - Financial Analysis Review Summary ScinoPharm Taiwan, Ltd. (ScinoPharm) is a pharmace...

11 Feb 2014 GlobalData 24 $125.00

Scinopharm Taiwan Limited (1789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Scinopharm Taiwan Limited (1789) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ScinoPharm Taiwan, Ltd....

24 Jan 2014 GlobalData 22 $250.00